1 | 10-mg dose of E5501-P21% powder | - | - | - | - | [1] 63 63 |
2 | 23-valent pneumococcal polysaccharide vaccine | - | - | - | - | [3] 13 13, 46, 53 |
3 | 23-valent pneumococcal polysaccharide vaccine (23-PPV) | - | - | - | - | [1] 13 13 |
4 | 23-valent polysaccharide pneumococcal vaccine | - | - | - | - | [1] 96 96 |
5 | 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM) | - | - | - | - | [2] 96 96, 97 |
6 | 2L polyethylene glycol/ascorbic acid | [2] Ascorbic acid Ascorbic acid (Synonym: Vit C W Calc-mag and Potass Powder), Polyethylene glycol | [2] D00018
D00018
,
D03370
(Name: Polyethylene glycol 3350) | - | - | [1] 97 97 |
7 | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream (Synonym: POINT OF CARE LM 2.5) | [2] Estradiol Estradiol, Lidocaine (Synonym: Polysporin Complete) | [11] D00105
D00105
,
D00358
,
D01413
,
D01617
,
D01953
,
D02086
(Name: POINT OF CARE LM 2.5),
D04061
,
D04063
,
D04064
,
D04065
,
D08127
| [7] ESR1 ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Breast cancer, Chemical carcinogenesis - receptor activation, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 💬 | [1] 226 226 |
8 | ?-3 polyunsaturated fatty acid | - | - | - | - | [1] 96 96 |
9 | [F-18] Fluorodopa Positron Emission Tomography | - | - | - | - | [1] 6 6 |
10 | ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml | [1] Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | [2] 61 61, 62 |
11 | ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML | [1] Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | [2] 62 62, 66 |
12 | Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil (Synonym: POINT OF CARE L2) | [4] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Mycophenolate mofetil, Mycophenolic acid, Prednisone | [11] D00407
D00407
,
D00473
,
D00751
,
D00752
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
,
D05094
,
D05095
,
D05096
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 49 49 |
13 | Administration of methylprednisolone, paracetamol and dexchlorpheniramine (Synonym: POINT OF CARE L2) | [3] Acetaminophen Acetaminophen (Synonym: Ready America First Aid Pocket - 33 Pieces), Dexchlorpheniramine, Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [8] D00217
D00217
,
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
,
D07803
| [4] HRH1 HRH1, NR3C1, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 49 49 |
14 | Administration of rituximab and methylprednisolone (Synonym: POINT OF CARE L2) | [2] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Rituximab | [7] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D02994
,
D05000
,
D05001
,
D05002
| [2] MS4A1 MS4A1, NR3C1 💬 | [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 |
15 | ADVATE 1000 IU powder and solvent for solution for injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] D02958
D02958
| - | - | [1] 288 288 |
16 | ADVATE 1000IU powder and solvent for solution for injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] D02958
D02958
| - | - | [1] 288 288 |
17 | ADVATE 500 IU powder and solvent for solution for injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] D02958
D02958
| - | - | [1] 288 288 |
18 | Alga Dunaliella Bardawil powder | - | - | - | - | [1] 90 90 |
19 | Alicalm (polymeric liquid formula) | - | - | - | - | [1] 96 96 |
20 | Alkalinized Lidocaine-Heparin (Synonym: POINT OF CARE LM 2.5) | [2] Heparin Heparin, Lidocaine (Synonym: Polysporin Complete) | [4] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D07510
,
D08127
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | [4] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬 | [1] 226 226 |
21 | Allogeneic skin-derived ABCB5-positive mesenchymal stem cells | - | - | - | - | [1] 36 36 |
22 | American Ginseng (Synonym: Powdered ginseng (JP18)) | [2] Ginseng Ginseng (Synonym: Ginsamin Power), Panax quinquefolius whole | [1] D06772
D06772
(Name: Powdered ginseng (JP18)) | - | - | [1] 13 13 |
23 | American ginseng extract HT-1001 (Synonym: Powdered ginseng (JP18)) | [2] Ginseng Ginseng (Synonym: Ginsamin Power), Panax quinquefolius whole | [1] D06772
D06772
(Name: Powdered ginseng (JP18)) | - | - | [1] 13 13 |
24 | Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [2] D02004
D02004
,
D07460
| [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
25 | Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [2] D02004
D02004
,
D07460
| [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
26 | Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [2] D02004
D02004
,
D07460
| [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
27 | Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [2] D02004
D02004
,
D07460
| [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
28 | Apomorphine Nasal Powder | [1] Apomorphine Apomorphine | [2] D02004
D02004
,
D07460
| [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
29 | Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population | - | - | - | - | [1] 96 96 |
30 | Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3) | - | - | - | - | [1] 13 13 |
31 | Avian polyclonal IgY antibody against PA | - | - | - | - | [1] 299 299 |
32 | AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE | [1] Interferon beta-1a Interferon beta-1a | [1] D04554
D04554
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
33 | Axially Oscillating Sphere dry powder inhaler (AOS DPI) | - | - | - | - | [1] 86 86 |
34 | Behavioral: Flexibility and postural exercise | - | - | - | - | [1] 299 299 |
35 | BENLYSTA - 120 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 120 MG 1 FLACONCINO | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 53 53 |
36 | Benlysta 400 mg powder for concentrate for solution for infusion | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 43 43, 49 |
37 | Benlysta 400 mg powder for concentrate for solution for infusions | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
38 | Benlysta 400mg polvere per concentrato per soluzione per infusione | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 43 43 |
39 | Betaferon 250 microgram/ml, powder and solvent for solution for injection | [1] Interferon beta-1b Interferon beta-1b | [1] D00746
D00746
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
40 | Betaferon 250 microgram/mL, powder and solvent for solution for injection. | [1] Interferon beta-1b Interferon beta-1b | [1] D00746
D00746
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
41 | Bladder instillation with heparin/ lidocaine (Synonym: POINT OF CARE LM 2.5) | [2] Heparin Heparin, Lidocaine (Synonym: Polysporin Complete) | [4] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D07510
,
D08127
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | [4] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬 | [1] 226 226 |
42 | Blood Collection for PK Testing (15 minutes post injection) | - | - | - | - | [1] 46 46 |
43 | Blood Collection for PK Testing (18-20 hours post injection) | - | - | - | - | [1] 46 46 |
44 | Blood Collection for PK Testing (180 minutes post injection) | - | - | - | - | [1] 46 46 |
45 | Blood Collection for PK Testing (60 minutes post injection) | - | - | - | - | [1] 46 46 |
46 | Bof-, Mazelen-, Rubellavaccin, poeder voor injectievloeistof | - | - | - | - | [1] 107 107 |
47 | Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System | [1] Brimonidine Brimonidine | [2] D02076
D02076
,
D07540
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 |
48 | Bupivacaine (Synonym: POINT OF CARE KIT KM) | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
(Name: POINT OF CARE KIT KM),
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [8] 46 46, 51, 53, 70, 96, 168, 226, 298 |
49 | BUPIVACAINE HYDROCHLORIDE (Synonym: POINT OF CARE KIT KM) | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
(Name: POINT OF CARE KIT KM),
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [2] 46 46, 53 |
50 | Bupivacaine hydrochloride 0.5% (Marcaine, Pfizer) (Synonym: POINT OF CARE KIT KM) | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
(Name: POINT OF CARE KIT KM),
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 46 46 |
51 | Bupivacaine Injection 0.5% (Synonym: POINT OF CARE KIT KM) | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
(Name: POINT OF CARE KIT KM),
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 168 168 |
52 | Bupivacaine, triamcinolone, and heparin (BTH) (Synonym: POINT OF CARE KIT KM) | [3] Bupivacaine Bupivacaine, Heparin, Triamcinolone (Synonym: Point Of Care Kit KM) | [8] D00385
D00385
,
D00983
,
D00984
,
D00985
,
D01450
(Name: POINT OF CARE KIT KM),
D06216
,
D07510
,
D07552
| [7] NR3C1 NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction 💬 | [1] 226 226 |
53 | Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine (Synonym: POINT OF CARE KIT KM) | [3] Bupivacaine Bupivacaine, Clonidine, Epinephrine (Synonym: Posicaine N) | [7] D00095
D00095
,
D00281
,
D00604
,
D00996
,
D01450
(Name: POINT OF CARE KIT KM),
D02149
,
D07552
| [14] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 70 70 |
54 | Bupivacaine/epinephrine/dexamethasone (Synonym: POINT OF CARE KIT KM) | [3] Bupivacaine Bupivacaine, Dexamethasone (Synonym: Neo-poly-dex), Epinephrine (Synonym: Posicaine N) | [14] D00095
D00095
,
D00292
,
D00975
,
D00996
,
D01450
(Name: POINT OF CARE KIT KM),
D01510
,
D01615
,
D01632
,
D01948
,
D02149
,
D02174
,
D02591
,
D02592
,
D07552
| [15] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 |
55 | Bydureon 2 mg powder and solvent for prolonged-release suspension | [2] Exenatide Exenatide, Manganese citrate | [1] D04121
D04121
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 6 6 |
56 | C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER | [1] Polyethylene glycol Polyethylene glycol | [1] D03370
D03370
(Name: Polyethylene glycol 3350) | - | - | [1] 276 276 |
57 | Calcium lactate (Synonym: Prequist powder (TN)) | [2] Calcium Calcium (Synonym: Calcium & Magnesium With Potassium & Zinc), Calcium lactate (Synonym: Calcium Lactate Powder) | [2] D00936
D00936
(Name: Prequist powder (TN)),
D02254
| - | - | [1] 235 235 |
58 | CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution | [1] Aztreonam Aztreonam | [2] D00240
D00240
,
D06558
| - | - | [1] 299 299 |
59 | Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie | [1] Ceftazidime Ceftazidime | [2] D00921
D00921
,
D07654
| - | - | [1] 299 299 |
60 | Ceftazidime and tobramycin (Synonym: TOBI PODHALER) | [2] Ceftazidime Ceftazidime, Tobramycin (Synonym: Tobi Podhaler) | [4] D00063
D00063
(Name: TOBI PODHALER),
D00921
,
D02542
,
D07654
| - | - | [1] 299 299 |
61 | Ceramic on Polyethylene articulation | - | - | - | - | [1] 46 46 |
62 | Cerezyme 400 Units Powder for concentrate for solution for infusion | [1] Imiglucerase Imiglucerase | [1] D03020
D03020
| [1] GBA GBA 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 |
63 | CFTR potentiator | - | - | - | - | [1] 299 299 |
64 | Ciprofloxacin (BAYQ3939) dry powder for inhalation | [1] Ciprofloxacin Ciprofloxacin | [2] D00186
D00186
,
D02216
| - | - | [1] 299 299 |
65 | Cohort 1: 1.0 x 10^8 PolyTregs | - | - | - | - | [1] 35 35 |
66 | Cohort 2: 2.5x10^8 PolyTregs | - | - | - | - | [1] 35 35 |
67 | COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML | - | - | - | - | [1] 299 299 |
68 | Comparator: diclofenac (Synonym: Diclofenac potassium) | [1] Diclofenac Diclofenac (Synonym: Ntp-diclofenac Potassium) | [3] D00903
D00903
(Name: Diclofenac potassium),
D00904
,
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
69 | Comparator: Diclofenac sodium (Synonym: Diclofenac potassium) | [1] Diclofenac Diclofenac (Synonym: Ntp-diclofenac Potassium) | [3] D00903
D00903
(Name: Diclofenac potassium),
D00904
,
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
70 | Corticosteroid treatment (Methylprednisolone or prednisolone) (Synonym: POINT OF CARE L2) | [2] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Prednisolone | [14] D00407
D00407
,
D00472
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 64 64 |
71 | Cyclophosphamide post transplant | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [1] 65 65 |
72 | Cyclophosphamide, Azathioprine,prednisone,methylprednisolone (Synonym: POINT OF CARE L2) | [4] Azathioprine Azathioprine, Cyclophosphamide, Methylprednisolone (Synonym: Point Of Care LM DEP 2), Prednisone | [11] D00238
D00238
,
D00287
,
D00407
,
D00473
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D03033
,
D05000
,
D05001
,
D05002
,
D07760
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 |
73 | Cyclosporine A dry powder inhalation (Drug) | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 |
74 | Daratumumab and pomalidomide | [2] Daratumumab Daratumumab, Pomalidomide | [2] D08976
D08976
(Name: Pomalidomide),
D10777
| [3] CD38 CD38, IL6, TNF 💬 | [86] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Nicotinate and nicotinamide metabolism, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salivary secretion, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 |
75 | Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland). | [1] Dexamethasone Dexamethasone (Synonym: Neo-poly-dex) | [9] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 235 235 |
76 | Dextromethorphan (Synonym: Dextromethorphan polistirex) | [1] Dextromethorphan Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz) | [3] D00848
D00848
,
D03742
,
D03744
(Name: Dextromethorphan polistirex) | [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [11] 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
77 | Dextromethorphan 30 mg (Synonym: Dextromethorphan polistirex) | [1] Dextromethorphan Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz) | [3] D00848
D00848
,
D03742
,
D03744
(Name: Dextromethorphan polistirex) | [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [2] 96 96, 97 |
78 | Dextromethorphan and Caffeine (Synonym: Dextromethorphan polistirex) | [2] Caffeine Caffeine (Synonym: Reese Headache Powders), Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz) | [5] D00528
D00528
,
D00848
,
D01453
,
D03742
,
D03744
(Name: Dextromethorphan polistirex) | [17] ADORA1 ADORA1, ADORA2A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, SIGMAR1 💬 | [37] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 78 78 |
79 | Dextromethorphan HBr and quinidine sulfate (Synonym: Dextromethorphan polistirex) | [3] Dextromethorphan Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz), Quinidine, Sulfate ion | [7] D00642
D00642
,
D00643
(Name: Quinidine polygalacturonate),
D00848
,
D02272
,
D03742
,
D03744
(Name: Dextromethorphan polistirex),
D08458
| [11] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | [22] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [1] 2 2 |
80 | DEXTROMETHORPHAN HYDROBROMIDE (Synonym: Dextromethorphan polistirex) | [1] Dextromethorphan Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz) | [3] D00848
D00848
,
D03742
,
D03744
(Name: Dextromethorphan polistirex) | [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [2] 13 13, 46 |
81 | Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg (Synonym: Dextromethorphan polistirex) | [3] Dextromethorphan Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz), Quinidine, Sulfate ion | [7] D00642
D00642
,
D00643
(Name: Quinidine polygalacturonate),
D00848
,
D02272
,
D03742
,
D03744
(Name: Dextromethorphan polistirex),
D08458
| [11] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | [22] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [2] 2 2, 13 |
82 | Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg (Synonym: Dextromethorphan polistirex) | [3] Dextromethorphan Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz), Quinidine, Sulfate ion | [7] D00642
D00642
,
D00643
(Name: Quinidine polygalacturonate),
D00848
,
D02272
,
D03742
,
D03744
(Name: Dextromethorphan polistirex),
D08458
| [11] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | [22] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [2] 2 2, 13 |
83 | Dextromethorphan/Quinidine (Synonym: Dextromethorphan polistirex) | [2] Dextromethorphan Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz), Quinidine | [7] D00642
D00642
,
D00643
(Name: Quinidine polygalacturonate),
D00848
,
D02272
,
D03742
,
D03744
(Name: Dextromethorphan polistirex),
D08458
| [11] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | [22] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
84 | Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg) (Synonym: Dextromethorphan polistirex) | [2] Dextromethorphan Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz), Quinidine | [7] D00642
D00642
,
D00643
(Name: Quinidine polygalacturonate),
D00848
,
D02272
,
D03742
,
D03744
(Name: Dextromethorphan polistirex),
D08458
| [11] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | [22] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [1] 8 8 |
85 | Diagnostic Test: Endogenous thrombin potential | [1] Thrombin Thrombin | [1] D00090
D00090
| - | - | [2] 86 86, 88 |
86 | Diagnostic Test: Nicotine and cotinine serum levels (Synonym: Nicotine polacrilex) | [1] Nicotine Nicotine (Synonym: Nicotac Nicotine Polacrilex Coated Cinnamon) | [3] D03365
D03365
,
D05156
,
D05157
(Name: Nicotine polacrilex) | [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [7] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | [1] 13 13 |
87 | Diagnostic Test: Positive and Negative Affect Scale (PANAS) | - | - | - | - | [1] 6 6 |
88 | Diagnostic Test: Postoperative laboratory blood tests at 24 hour | - | - | - | - | [1] 235 235 |
89 | Diagnostic Test: Postoperative laboratory blood tests at 6 hour | - | - | - | - | [1] 235 235 |
90 | Diagnostic Test: Postoperative laboratory drainage fluid tests at 24 hour | - | - | - | - | [1] 235 235 |
91 | Diagnostic Test: PTH measurements post-thyroidectomy (at 5 and 60 min post thyroid removal) | - | - | - | - | [1] 235 235 |
92 | Diclofenac (Synonym: Diclofenac potassium) | [1] Diclofenac Diclofenac (Synonym: Ntp-diclofenac Potassium) | [3] D00903
D00903
(Name: Diclofenac potassium),
D00904
,
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [5] 13 13, 34, 46, 78, 271 |
93 | Diclofenac + Omeprazole (Synonym: Diclofenac potassium) | [2] Diclofenac Diclofenac (Synonym: Ntp-diclofenac Potassium), Omeprazole | [7] D00455
D00455
,
D00903
(Name: Diclofenac potassium),
D00904
,
D01207
,
D05259
,
D05261
,
D07816
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
94 | Diclofenac 50 milligrams (Synonym: Diclofenac potassium) | [1] Diclofenac Diclofenac (Synonym: Ntp-diclofenac Potassium) | [3] D00903
D00903
(Name: Diclofenac potassium),
D00904
,
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
95 | Diclofenac Sodium (Synonym: Diclofenac potassium) | [1] Diclofenac Diclofenac (Synonym: Ntp-diclofenac Potassium) | [3] D00903
D00903
(Name: Diclofenac potassium),
D00904
,
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 34 34, 46 |
96 | Diclofenac sodium topical gel (Synonym: Diclofenac potassium) | [1] Diclofenac Diclofenac (Synonym: Ntp-diclofenac Potassium) | [3] D00903
D00903
(Name: Diclofenac potassium),
D00904
,
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 |
97 | Diclofenac SR (Synonym: Diclofenac potassium) | [1] Diclofenac Diclofenac (Synonym: Ntp-diclofenac Potassium) | [3] D00903
D00903
(Name: Diclofenac potassium),
D00904
,
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
98 | Dimebon + Dextromethorphan (Synonym: Dextromethorphan polistirex) | [2] Dextromethorphan Dextromethorphan (Synonym: Alka-Seltzer Plus Severe Cold Night PowerFast Fizz), Latrepirdine | [4] D00848
D00848
,
D03742
,
D03744
(Name: Dextromethorphan polistirex),
D09917
| [7] ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | [22] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 |
99 | Diosminex, 500 mg, tabletki powlekane | - | - | - | - | [1] 265 265 |
100 | Dry powder tobramycin | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
101 | Egg Albumen Powder | [2] Egg Egg, Egg white | - | - | - | [1] 96 96 |
102 | Eliglustat Tartrate – Powder for Oral Suspension | [1] Eliglustat Eliglustat | [1] D09893
D09893
| [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 |
103 | ENBREL - 50 MG POLV SOLUZ INIET SOTTOC. POLV. FLAC VETRO SOLV. SIRI. VET. SOLV 1 ML (50 MG/ML) 12 FLAC+12 SIRI. PRE+12 AGHI+12 ADAT PER FLAC+24 TAMP. PRE INIEZ | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
104 | Enbrel 25 mg powder and solvent for solution for injection | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
105 | ENBREL 25 mg/ml polvo y disolvente para solución inyectable para uso pediátrico | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 |
106 | Enbrel 50 mg powder and solvent for solution for injection | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
107 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 |
108 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
109 | ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 |
110 | ERCP with Bupivacaine infusion (Synonym: POINT OF CARE KIT KM) | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
(Name: POINT OF CARE KIT KM),
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 298 298 |
111 | Esomeprazole (Synonym: Esomeprazole potassium) | [1] Esomeprazole Esomeprazole | [4] D01984
D01984
,
D04056
,
D07917
,
D09339
(Name: Esomeprazole potassium) | [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [8] 13 13, 46, 86, 98, 107, 113, 298, 299 |
112 | Esomeprazole 20 mg (Synonym: Esomeprazole potassium) | [1] Esomeprazole Esomeprazole | [4] D01984
D01984
,
D04056
,
D07917
,
D09339
(Name: Esomeprazole potassium) | [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 46 46 |
113 | Ezogabine (Synonym: Potiga (TN)) | [1] Ezogabine Ezogabine (Synonym: Potiga) | [1] D09569
D09569
(Name: Potiga (TN)) | [5] KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 | [6] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | [2] 2 2, 144 |
114 | EZOGABINE (US ONLY) (Synonym: Potiga (TN)) | [1] Ezogabine Ezogabine (Synonym: Potiga) | [1] D09569
D09569
(Name: Potiga (TN)) | [5] KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 | [6] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | [1] 144 144 |
115 | Ezogabine/retigabine (Synonym: Potiga (TN)) | [1] Ezogabine Ezogabine (Synonym: Potiga) | [1] D09569
D09569
(Name: Potiga (TN)) | [5] KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 | [6] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | [1] 144 144 |
116 | FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO | [1] Agalsidase beta Agalsidase beta | [1] D03228
D03228
| [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 |
117 | FENFLURAMINE (Synonym: Ponderax (TN)) | [1] Fenfluramine Fenfluramine (Synonym: Pondimin Tab 20mg) | [1] D07945
D07945
(Name: Ponderax (TN)) | [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [4] 140 140, 144, 145, 149 |
118 | Fenfluramine HCl, DL-Fenfluramine, (±)-Fenfluramine (Synonym: Ponderax (TN)) | [1] Fenfluramine Fenfluramine (Synonym: Pondimin Tab 20mg) | [1] D07945
D07945
(Name: Ponderax (TN)) | [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 144 144 |
119 | FENFLURAMINE HYDROCHLORIDE (Synonym: Ponderax (TN)) | [1] Fenfluramine Fenfluramine (Synonym: Pondimin Tab 20mg) | [1] D07945
D07945
(Name: Ponderax (TN)) | [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 140 140, 144 |
120 | FENFLURAMINE HYDROCHLORIDE (colorless) (Synonym: Ponderax (TN)) | [1] Fenfluramine Fenfluramine (Synonym: Pondimin Tab 20mg) | [1] D07945
D07945
(Name: Ponderax (TN)) | [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 140 140, 144 |
121 | FENFLURAMINE HYDROCHLORIDE (red) (Synonym: Ponderax (TN)) | [1] Fenfluramine Fenfluramine (Synonym: Pondimin Tab 20mg) | [1] D07945
D07945
(Name: Ponderax (TN)) | [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 140 140 |
122 | Fetal porcine cells, Neurocell-PD | - | - | - | - | [1] 6 6 |
123 | Finely ground flaxseed powder | [1] Flax seed Flax seed | - | - | - | [1] 299 299 |
124 | Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution | [1] Flucloxacillin Flucloxacillin | [3] D01249
D01249
,
D04196
,
D07965
| - | - | [1] 299 299 |
125 | Fluticasone Propionate, 800 mcg twice daily (post 4FED failure) | [1] Fluticasone propionate Fluticasone propionate | [1] D01708
D01708
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
126 | FORLAX 4 g, poudre pour solution buvable en sachet | - | - | - | - | [1] 299 299 |
127 | Four-point cane (FPC) | - | - | - | - | [1] 13 13 |
128 | Freeze-dried black raspberry powder | [1] Raspberry Raspberry | [1] D09179
D09179
| - | - | [1] 97 97 |
129 | Generic Dry Powder Inhaler | - | - | - | - | [1] 86 86 |
130 | Genetic: Genetic test: ACE polymorphism | - | - | - | - | [3] 3 3, 15, 256 |
131 | Genetic: Genetic test: ACTN3 polymorphism | - | - | - | - | [3] 3 3, 15, 256 |
132 | Genetic: Nicotine dependence (Synonym: Nicotine polacrilex) | [1] Nicotine Nicotine (Synonym: Nicotac Nicotine Polacrilex Coated Cinnamon) | [3] D03365
D03365
,
D05156
,
D05157
(Name: Nicotine polacrilex) | [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [7] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | [1] 13 13 |
133 | Genetic: polymerase chain reaction | - | - | - | - | [2] 28 28, 60 |
134 | Genetic: Polymorphism Analysis | - | - | - | - | [2] 49 49, 60 |
135 | Genotonorm Kabipen 5.3 mg polvo y disolvente para sol. inyectable (Marca internacional Genotropin) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
136 | Genotonorm Kabipen 5.3 mg polvo y disolvente para solución inyectable (Marca internacional Genotropin) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
137 | GENOTROPIN 12 mg powder and solvent for solution for injection. | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
138 | Ginger (Synonym: Powdered ginger (JP18)) | [1] Ginger Ginger | [1] D06744
D06744
(Name: Powdered ginger (JP18)) | - | - | [2] 46 46, 271 |
139 | Ginseng (Synonym: Powdered ginseng (JP18)) | [1] Ginseng Ginseng (Synonym: Ginsamin Power) | [1] D06772
D06772
(Name: Powdered ginseng (JP18)) | - | - | [3] 13 13, 46, 53 |
140 | GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.) | - | - | - | - | [1] 299 299 |
141 | Green Tea Polyphenols (EGCG/ECG) | [2] Epigallocatechin gallate Epigallocatechin gallate, Green tea leaf (Synonym: Camellia Sinensis Leaf Powder) | [1] D06903
D06903
| - | - | [1] 6 6 |
142 | Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide'' | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [1] 60 60 |
143 | Heparin & Alkalinized Lidocaine Bladder Instillation (Synonym: POINT OF CARE LM 2.5) | [2] Heparin Heparin, Lidocaine (Synonym: Polysporin Complete) | [4] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D07510
,
D08127
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | [4] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬 | [1] 226 226 |
144 | Heparin 25mg inhalation powder, hard capsule | [1] Heparin Heparin | [1] D07510
D07510
| [1] SERPINC1 SERPINC1 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 299 299 |
145 | HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML | [1] Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | [3] 61 61, 62, 66 |
146 | Histamine (Synonym: POSITIVE SKIN TEST CONTROL - HISTAMINE) | [1] Histamine Histamine (Synonym: Ponos Natural Pain Relief) | [1] D08040
D08040
(Name: POSITIVE SKIN TEST CONTROL - HISTAMINE) | [4] HRH1 HRH1, HRH2, HRH3, HRH4 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
147 | Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh | - | - | - | - | [1] 36 36 |
148 | Humatrope® 6 mg, powder and solvent for solution for injection | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
149 | Hydroxychloroquine (Synonym: Polirreumin (TN)) | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [27] 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
150 | Hydroxychloroquine (Z0188) (Synonym: Polirreumin (TN)) | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [1] 49 49 |
151 | Hydroxychloroquine + low-dose prednisone (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Prednisone | [2] D00473
D00473
,
D08050
(Name: Polirreumin (TN)) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 |
152 | Hydroxychloroquine + Prednisone (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Prednisone | [2] D00473
D00473
,
D08050
(Name: Polirreumin (TN)) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 |
153 | Hydroxychloroquine 400mg/d (Synonym: Polirreumin (TN)) | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [1] 53 53 |
154 | Hydroxychloroquine and Indapamide (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Indapamide | [3] D00345
D00345
,
D06401
,
D08050
(Name: Polirreumin (TN)) | [1] SLC12A3 SLC12A3 💬 | - | [1] 13 13 |
155 | Hydroxychloroquine higher dose (Synonym: Polirreumin (TN)) | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [1] 90 90 |
156 | Hydroxychloroquine lower dose (Synonym: Polirreumin (TN)) | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [1] 90 90 |
157 | Hydroxychloroquine or Chloroquine (Synonym: Polirreumin (TN)) | [2] Chloroquine Chloroquine, Hydroxychloroquine | [4] D02125
D02125
,
D02366
,
D03469
,
D08050
(Name: Polirreumin (TN)) | - | - | [1] 49 49 |
158 | Hydroxychloroquine reduced (Synonym: Polirreumin (TN)) | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [1] 49 49 |
159 | HYDROXYCHLOROQUINE SULFATE (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Sulfate ion | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [3] 46 46, 53, 66 |
160 | Hydroxychloroquine Sulfate 100 milligram (mg) Tab (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Sulfate ion | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [1] 218 218 |
161 | HYDROXYCHLOROQUINE SULPHATE (Synonym: Polirreumin (TN)) | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [1] 96 96 |
162 | IDPM: Inhaled Dry Powder Mannitol | [1] Mannitol Mannitol | [1] D00062
D00062
| - | - | [1] 299 299 |
163 | IDURONATE-2-SULFATASE FUSED TO A FC POLYPEPTIDE THAT BINDS TO THE HUMAN TRANSFERRIN RECEPTOR | - | - | - | - | [1] 19 19 |
164 | Immediate post operative bioassay of Parathyroid Hormone | [1] Parathyroid hormone Parathyroid hormone | [1] D05364
D05364
| [2] PTH1R PTH1R, PTH2R 💬 | [3] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 |
165 | INFLECTRA - 100 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 1 FLACONCINO | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 56 56 |
166 | Inflectra 100 mg powder for concentrate for solution for infusion | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
167 | Infliximab, methylprednisolone, methotrexate (Synonym: POINT OF CARE L2) | [3] Infliximab Infliximab, Methotrexate, Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [9] D00142
D00142
,
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D02115
,
D02598
,
D05000
,
D05001
,
D05002
| [4] DHFR DHFR, DHFR2, NR3C1, TNF 💬 | [72] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
168 | Inhaled Dry Powder Mannitol | [1] Mannitol Mannitol | [1] D00062
D00062
| - | - | [1] 299 299 |
169 | Inhaled dry powder treprostinil (LIQ861) | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
170 | Inhaled tobramycin (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
171 | Injections on posterior bladder wall excluding the trigone | - | - | - | - | [1] 226 226 |
172 | Interferon-beta-1a (Avonex) plus methylprednisolone (Synonym: POINT OF CARE L2) | [3] Human interferon beta Human interferon beta, Interferon beta-1a, Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [7] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D04554
,
D05000
,
D05001
,
D05002
| [3] IFNAR1 IFNAR1, IFNAR2, NR3C1 💬 | [19] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
173 | Intravenous (i.v.) methylprednisolone 1000 mg, total 9 (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 |
174 | Intravenous Infusion of Diclofenac Sodium (Synonym: Diclofenac potassium) | [1] Diclofenac Diclofenac (Synonym: Ntp-diclofenac Potassium) | [3] D00903
D00903
(Name: Diclofenac potassium),
D00904
,
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 78 78 |
175 | Intravenous Methylprednisolone (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 145 |
176 | IV methylprednisolone (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
177 | IV methylprednisolone (steroids) (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
178 | IV tobramycin (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
179 | JINARC - 15 MG +45 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28X15 MG + 28 X 45 MG) | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
180 | JINARC - 30 MG + 60 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 60 MG) | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
181 | JINARC - 30 MG +90 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 90 MG) | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
182 | Korean Red Ginseng (Synonym: Powdered ginseng (JP18)) | [1] Ginseng Ginseng (Synonym: Ginsamin Power) | [1] D06772
D06772
(Name: Powdered ginseng (JP18)) | - | - | [1] 53 53 |
183 | Lap TAP Bupivacaine/Epinephrine (Synonym: POINT OF CARE KIT KM) | [2] Bupivacaine Bupivacaine, Epinephrine (Synonym: Posicaine N) | [5] D00095
D00095
,
D00996
,
D01450
(Name: POINT OF CARE KIT KM),
D02149
,
D07552
| [14] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 |
184 | Leflunomide-Sulfasalazine-Hydroxychloroquine (Synonym: Polirreumin (TN)) | [3] Hydroxychloroquine Hydroxychloroquine, Leflunomide, Sulfasalazine | [3] D00448
D00448
,
D00749
,
D08050
(Name: Polirreumin (TN)) | [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
185 | Lenabasum 20 mg Powder in Capsule | - | - | - | - | [1] 51 51 |
186 | Lenabasum 5 mg Powder in Capsule | - | - | - | - | [1] 51 51 |
187 | Lenabasum 5mg Powder in Capsule | - | - | - | - | [1] 51 51 |
188 | Levodopa powder for inhalation | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
189 | Licorice (Synonym: Powdered glycyrrhiza (JP18)) | [1] Licorice Licorice | [1] D04365
D04365
(Name: Powdered glycyrrhiza (JP18)) | - | - | [1] 53 53 |
190 | Lidocaine (Synonym: POINT OF CARE LM 2.5) | [1] Lidocaine Lidocaine (Synonym: Polysporin Complete) | [3] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [12] 6 6, 13, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256 |
191 | Lidocaine 1% Injectable Solution (Synonym: POINT OF CARE LM 2.5) | [1] Lidocaine Lidocaine (Synonym: Polysporin Complete) | [3] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 34 34 |
192 | Lidocaine 2% without vessel constrictor (Synonym: POINT OF CARE LM 2.5) | [1] Lidocaine Lidocaine (Synonym: Polysporin Complete) | [3] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 51 51 |
193 | Lidocaine Hydrochloride, Injectable (Synonym: POINT OF CARE LM 2.5) | [1] Lidocaine Lidocaine (Synonym: Polysporin Complete) | [3] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 70 70 |
194 | Lidocaine Injection 2% (Synonym: POINT OF CARE LM 2.5) | [1] Lidocaine Lidocaine (Synonym: Polysporin Complete) | [3] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 168 168 |
195 | Lidocaine patch 5% (Synonym: POINT OF CARE LM 2.5) | [1] Lidocaine Lidocaine (Synonym: Polysporin Complete) | [3] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 13 13 |
196 | Lidocaine Releasing Intravesical System - LiRIS® (Synonym: POINT OF CARE LM 2.5) | [1] Lidocaine Lidocaine (Synonym: Polysporin Complete) | [3] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 226 226 |
197 | Liposomal bupivacaine (Synonym: POINT OF CARE KIT KM) | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
(Name: POINT OF CARE KIT KM),
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [3] 51 51, 70, 96 |
198 | Liposomed polyphenols resveratrol and curcumin | [2] Curcumin Curcumin, Resveratrol | - | - | - | [1] 2 2 |
199 | Liprotamase Powder for Oral Solution | - | - | - | - | [1] 299 299 |
200 | Lisinopril, losartan, and atorvastatin (Synonym: Losartan potassium) | [3] Atorvastatin Atorvastatin, Lisinopril, Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide) | [7] D00258
D00258
,
D00357
(Name: Losartan potassium),
D00362
,
D00887
,
D07474
,
D08131
,
D08146
| [3] ACE ACE, AGTR1, HMGCR 💬 | [22] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
201 | Local Anesthesia (lidocaine hydrochloride) (Synonym: POINT OF CARE LM 2.5) | [1] Lidocaine Lidocaine (Synonym: Polysporin Complete) | [3] D00358
D00358
,
D02086
(Name: POINT OF CARE LM 2.5),
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 6 6 |
202 | Losartan (Synonym: Losartan potassium) | [1] Losartan Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide) | [2] D00357
D00357
(Name: Losartan potassium),
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [18] 17 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
203 | Losartan and Atenolol or Propranolol (Synonym: Losartan potassium) | [3] Atenolol Atenolol, Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide), Propranolol | [5] D00235
D00235
,
D00357
(Name: Losartan potassium),
D00483
,
D08146
,
D08443
| [4] ADRB1 ADRB1, ADRB2, ADRB3, AGTR1 💬 | [23] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 167 167 |
204 | Losartan and nebivolol (Synonym: Losartan potassium) | [2] Losartan Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide), Nebivolol | [3] D00357
D00357
(Name: Losartan potassium),
D05127
,
D08146
| [2] ADRB1 ADRB1, AGTR1 💬 | [22] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 167 167 |
205 | Losartan and other angiotensin receptor blockers (Synonym: Losartan potassium) | [2] Angiotensin II Angiotensin II, Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide) | [4] D00150
D00150
,
D00357
(Name: Losartan potassium),
D02014
,
D08146
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 19 19 |
206 | Losartan Bluefish 50 mg (Synonym: Losartan potassium) | [2] Bluefish Bluefish, Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide) | [2] D00357
D00357
(Name: Losartan potassium),
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
207 | Losartan HEXAL (Synonym: Losartan potassium) | [1] Losartan Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide) | [2] D00357
D00357
(Name: Losartan potassium),
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 36 36 |
208 | LOSARTAN POTASICO | [1] Losartan Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide) | [2] D00357
D00357
(Name: Losartan potassium),
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 179 179 |
209 | LOSARTAN POTASSIUM | [2] Losartan Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide), Potassium | [3] D00357
D00357
(Name: Losartan potassium),
D08146
,
D08403
(Name: Potassium) | [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [5] 36 36, 98, 167, 179, 215 |
210 | Losartan Tablets & QingReMoShen Granule (Synonym: Losartan potassium) | [1] Losartan Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide) | [2] D00357
D00357
(Name: Losartan potassium),
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
211 | Lym-X-Sorb powder | - | - | - | - | [1] 299 299 |
212 | Lyophilized etanercept powder(Yisaipu) | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 |
213 | Mango polyphenolics | [1] Mango Mango | - | - | - | [2] 96 96, 97 |
214 | Mannitol inhalation powder | [1] Mannitol Mannitol | [1] D00062
D00062
| - | - | [1] 299 299 |
215 | MCT powder | - | - | - | - | [1] 296 296 |
216 | Megadose oral methylprednisolone (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
217 | Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) | - | - | - | - | [1] 13 13 |
218 | MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC | [1] Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | - | - | - | [2] 62 62, 66 |
219 | MENVEO – Polvere e soluzione per soluzione iniettabile | [1] Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | - | - | - | [2] 61 61, 62 |
220 | Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie | [1] Meropenem Meropenem | [2] D02222
D02222
,
D08185
| - | - | [1] 299 299 |
221 | Metal on Polyethylene articulation | - | - | - | - | [1] 46 46 |
222 | Methotrexate + Methylprednisolone (Synonym: POINT OF CARE L2) | [2] Methotrexate Methotrexate, Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [8] D00142
D00142
,
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D02115
,
D05000
,
D05001
,
D05002
| [3] DHFR DHFR, DHFR2, NR3C1 💬 | [6] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | [1] 46 46 |
223 | Methotrexate + salazopyrine + hydroxychloroquine administration (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Methotrexate | [3] D00142
D00142
,
D02115
,
D08050
(Name: Polirreumin (TN)) | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
224 | Methotrexate-Sulfasalazine-Hydroxychloroquine (Synonym: Polirreumin (TN)) | [3] Hydroxychloroquine Hydroxychloroquine, Methotrexate, Sulfasalazine | [4] D00142
D00142
,
D00448
,
D02115
,
D08050
(Name: Polirreumin (TN)) | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
225 | Methylprednisolone (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
226 | Methylprednisolone (drug) (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
227 | Methylprednisolone (MP) (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 60 60, 285 |
228 | Methylprednisolone (MP) or prednisone (pred) (Synonym: POINT OF CARE L2) | [2] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Prednisone | [7] D00407
D00407
,
D00473
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
229 | Methylprednisolone (or other glucocorticoid) (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 |
230 | Methylprednisolone (Solu-Medrol) (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 14 14 |
231 | Methylprednisolone 1250 mg/24h x3 days (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
232 | METHYLPREDNISOLONE ACETATE (Synonym: POINT OF CARE L2) | [2] Acetate Acetate, Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 51 |
233 | Methylprednisolone and azathioprine (Synonym: POINT OF CARE L2) | [2] Azathioprine Azathioprine, Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [8] D00238
D00238
,
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D03033
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 93 93, 95 |
234 | Methylprednisolone and Mycophenolate mofetil (Synonym: POINT OF CARE L2) | [3] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Mycophenolate mofetil, Mycophenolic acid | [10] D00407
D00407
,
D00751
,
D00752
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
,
D05094
,
D05095
,
D05096
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [2] 93 93, 95 |
235 | Methylprednisolone bolus IV 15 mg/kg/d for 3 days. (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 |
236 | Methylprednisolone hemisuccinate (Synonym: POINT OF CARE L2) | [2] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Methylprednisolone hemisuccinate | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
237 | Methylprednisolone IV (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
238 | METHYLPREDNISOLONE MYLAN Générique (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
239 | Methylprednisolone or budesonide (Synonym: POINT OF CARE L2) | [2] Budesonide Budesonide, Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [7] D00246
D00246
,
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
240 | Methylprednisolone or Prednisolone (Synonym: POINT OF CARE L2) | [2] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Prednisolone | [14] D00407
D00407
,
D00472
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 |
241 | Methylprednisolone PO | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
242 | Methylprednisolone pulse (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 220 |
243 | METHYLPREDNISOLONE SODIUM HEMISUCCINATE (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 97 |
244 | METHYLPREDNISOLONE SODIUM SUCCINATE (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [6] 13 13, 46, 49, 50, 51, 211 |
245 | Methylprednisolone succinate (Synonym: POINT OF CARE L2) | [2] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Methylprednisolone hemisuccinate | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
246 | Methylprednisolone(intravenously in the 1st-2nd-3rd month ) (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
247 | Methylprednisolone(intravenously in the 1st-3rd-5th month) (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
248 | METILPREDNISOLONE HIKMA - 1000 MG POLVERE PER SOLUZIONE INIETTABILE 10 FLACONCINI IN VETRO | - | - | - | - | [1] 300 300 |
249 | Micellar Paclitaxel for Injection (Synonym: Paclitaxel poliglumex) | [1] Paclitaxel Paclitaxel | [2] D00491
D00491
,
D05333
(Name: Paclitaxel poliglumex) | [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 46 46 |
250 | Mogamulizumab (Synonym: Poteligeo (TN)) | [1] Mogamulizumab Mogamulizumab (Synonym: Poteligeo) | [1] D09761
D09761
(Name: Poteligeo (TN)) | [1] CCR4 CCR4 💬 | [5] Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Kaposi sarcoma-associated herpesvirus infection, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 26 26 |
251 | Multigrain powder (S) | - | - | - | - | [1] 46 46 |
252 | MYELOSTIM 34 milions UI/ml - powder and solvent for solution for injection/infusion | - | - | - | - | [1] 65 65 |
253 | MYELOSTIM 34 milions UI/ml, powder and solvent for solution for injection or infusion | - | - | - | - | [1] 65 65 |
254 | Myozyme 50 mg powder for concentrate for solution for infusion | [1] Alglucosidase alfa Alglucosidase alfa | [1] D03207
D03207
| [1] GAA GAA 💬 | [4] Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | [1] 256 256 |
255 | N-3 Polyunsaturated Fatty Acids | - | - | - | - | [1] 96 96 |
256 | N. MENINGITIDIS GROUP C POLYSACCHARIDE | - | - | - | - | [1] 14 14 |
257 | Nebcin (tobramycin) (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
258 | Nebulization tobramycin (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
259 | NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN | [1] Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Synonym: Adacel-polio) | - | - | - | [1] 50 50 |
260 | NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETA | [1] Triethylenetetramine Triethylenetetramine | - | - | - | [1] 50 50 |
261 | NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN | [1] Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Synonym: Adacel-polio) | - | - | - | [1] 50 50 |
262 | Nexium (esomeprazole magnesium) (Synonym: Esomeprazole potassium) | [2] Esomeprazole Esomeprazole, Magnesium (Synonym: Hi Potency Multi Tab) | [4] D01984
D01984
,
D04056
,
D07917
,
D09339
(Name: Esomeprazole potassium) | [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 298 298 |
263 | NICOTINE (Synonym: Nicotine polacrilex) | [1] Nicotine Nicotine (Synonym: Nicotac Nicotine Polacrilex Coated Cinnamon) | [3] D03365
D03365
,
D05156
,
D05157
(Name: Nicotine polacrilex) | [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [7] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | [3] 6 6, 13, 84 |
264 | Nicotine gum (Synonym: Nicotine polacrilex) | [1] Nicotine Nicotine (Synonym: Nicotac Nicotine Polacrilex Coated Cinnamon) | [3] D03365
D03365
,
D05156
,
D05157
(Name: Nicotine polacrilex) | [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [7] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | [1] 6 6 |
265 | Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY) (Synonym: Nicotine polacrilex) | [1] Nicotine Nicotine (Synonym: Nicotac Nicotine Polacrilex Coated Cinnamon) | [3] D03365
D03365
,
D05156
,
D05157
(Name: Nicotine polacrilex) | [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [7] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | [1] 6 6 |
266 | Nicotine patch (Synonym: Nicotine polacrilex) | [1] Nicotine Nicotine (Synonym: Nicotac Nicotine Polacrilex Coated Cinnamon) | [3] D03365
D03365
,
D05156
,
D05157
(Name: Nicotine polacrilex) | [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [7] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | [2] 6 6, 84 |
267 | Nicotine transdermal patch (Synonym: Nicotine polacrilex) | [1] Nicotine Nicotine (Synonym: Nicotac Nicotine Polacrilex Coated Cinnamon) | [3] D03365
D03365
,
D05156
,
D05157
(Name: Nicotine polacrilex) | [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [7] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | [1] 6 6 |
268 | Nocturnal oxygen , nocturnal bi-level positive pressure ventilation | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 299 299 |
269 | NPLATE 500 microgramos polvo para solución inyectable | [1] Romiplostim Romiplostim | [1] D08990
D08990
| [1] MPL MPL 💬 | [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 63 63 |
270 | Nucala 100 mg powder for solution for injection | [1] Mepolizumab Mepolizumab | [1] D04923
D04923
| [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2] 44 44, 45 |
271 | Ocrevus 300 mg, solution à diluer pour perfusion | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
272 | OCTANATE 100 UI/ml, poudre et solvant pour solution injectable | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 |
273 | OCTANATE 50 UI/ml, poudre et solvant pour solution injectable | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 |
274 | OligoG Dry powder for inhalation | - | - | - | - | [1] 299 299 |
275 | OMNIPAQUE - 300 MG I/ML SOLUZIONE INIETTABILE FLACONE IN POLIPROPILENE DA 50 ML | [1] Iohexol Iohexol | [1] D01817
D01817
| - | - | [1] 222 222 |
276 | Open label RAD001 (only used for post-extension phase) | - | - | - | - | [1] 158 158 |
277 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | [2] Mesalazine Mesalazine, Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [7] D00377
D00377
,
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
278 | Oral Methylprednisolone 625 mg/24h x3 days (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
279 | ORENCIA 250 mg polvo para concentrado para sol. para perfusión | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 46 46 |
280 | ORENCIA 250mg powder for concentrate for solution for infusion | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 46 46 |
281 | Other: 100% pomegranate juice | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 |
282 | Other: 4 Food Elimination Diet (post 1FED failure) | - | - | - | - | [1] 98 98 |
283 | Other: Dosage of Delta-aminolevulinic acid and Porphobilinogen | [2] Aminolevulinic acid Aminolevulinic acid, Porphobilinogen | [2] D02908
D02908
,
D07567
| - | - | [1] 254 254 |
284 | Other: Event-related evoked potential using electroencephalography (EEG). | - | - | - | - | [1] 6 6 |
285 | Other: Exposure to methylprednisolone during pregnancy (Synonym: POINT OF CARE L2) | [1] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2) | [6] D00407
D00407
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
286 | Other: general population | - | - | - | - | [2] 46 46, 271 |
287 | Other: Glucose -potentiated arginine (GPA) stimulation tests | [2] Arginine Arginine, Dextrose, unspecified form (Synonym: Potassium Chloride in Dextrose and Sodium Chloride) | [1] D02982
D02982
| - | - | [1] 299 299 |
288 | Other: Histamine (Synonym: POSITIVE SKIN TEST CONTROL - HISTAMINE) | [1] Histamine Histamine (Synonym: Ponos Natural Pain Relief) | [1] D08040
D08040
(Name: POSITIVE SKIN TEST CONTROL - HISTAMINE) | [4] HRH1 HRH1, HRH2, HRH3, HRH4 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
289 | Other: Hydroxychloroquine/Chloroquine (Synonym: Polirreumin (TN)) | [2] Chloroquine Chloroquine, Hydroxychloroquine | [4] D02125
D02125
,
D02366
,
D03469
,
D08050
(Name: Polirreumin (TN)) | - | - | [1] 46 46 |
290 | Other: Impact of biotherapy on postoperative morbidity in ulcerative colitis | - | - | - | - | [1] 97 97 |
291 | Other: Losartan (Synonym: Losartan potassium) | [1] Losartan Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide) | [2] D00357
D00357
(Name: Losartan potassium),
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 46 46 |
292 | Other: Position Sense | - | - | - | - | [1] 13 13 |
293 | Other: Postoperative nausea and vomiting at 24 hour | - | - | - | - | [1] 235 235 |
294 | Other: Postoperative nausea and vomiting at 6 hour | - | - | - | - | [1] 235 235 |
295 | Other: Postoperative pain at 24 hour | - | - | - | - | [1] 235 235 |
296 | Other: Postoperative pain at 6 hour | - | - | - | - | [1] 235 235 |
297 | Other: Postoperative sore throat and hoarseness at 24 hour | - | - | - | - | [1] 235 235 |
298 | Other: Postoperative sore throat and hoarseness at 6 hour | - | - | - | - | [1] 235 235 |
299 | Other: Potable water | [1] Water Water (Synonym: Ori-power) | [1] D00001
D00001
| - | - | [1] 19 19 |
300 | Other: Reaction Time and Postural Control | - | - | - | - | [1] 299 299 |
301 | Other: Review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. | [1] Melatonin Melatonin | [1] D08170
D08170
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 149 149 |
302 | Other: Sulfur Pool & Medicinal Mud | - | - | - | - | [1] 46 46 |
303 | Other: Tobramycin time of administration (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
304 | Other: Trunk position sense | - | - | - | - | [1] 13 13 |
305 | Other: Use of a postpartum diary and additional blood draws | - | - | - | - | [1] 288 288 |
306 | Other: Use of a postpartum diary and additional blood draws. | - | - | - | - | [1] 288 288 |
307 | Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254measured as amount of total protein containing the PorA P1.4 | - | - | - | - | [1] 11 11 |
308 | Ovastat 1000 mg, powder for solution for infusion | [1] Treosulfan Treosulfan | [1] D07253
D07253
| - | - | [1] 65 65 |
309 | Ovastat 5000 mg, powder for solution for infusion | [1] Treosulfan Treosulfan | [1] D07253
D07253
| - | - | [1] 65 65 |
310 | Paclitaxel (Synonym: Paclitaxel poliglumex) | [1] Paclitaxel Paclitaxel | [2] D00491
D00491
,
D05333
(Name: Paclitaxel poliglumex) | [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [2] 46 46, 85 |
311 | Pancreas Powder | - | - | - | - | [1] 299 299 |
312 | PANCREATIN (PAncreas Powder) | [1] Pancrelipase Pancrelipase (Synonym: Pancrex V Powder) | [1] D05349
D05349
| - | - | [1] 299 299 |
313 | PANCREATINA (Páncreas Polvo | - | - | - | - | [1] 299 299 |
314 | PANCREATINA (Páncreas Polvo) | - | - | - | - | [1] 299 299 |
315 | Pancrelipase/Pancreas Powder | [1] Pancrelipase Pancrelipase (Synonym: Pancrex V Powder) | [1] D05349
D05349
| - | - | [2] 298 298, 299 |
316 | Pegylated polypeptide hormone of human recombinant origin PEG-hGH | - | - | - | - | [1] 78 78 |
317 | PEMIROLAST (Synonym: Pemirolast potassium) | [1] Pemirolast Pemirolast | [2] D01088
D01088
(Name: Pemirolast potassium),
D07476
| - | - | [1] 113 113 |
318 | Pentosan Polysulfat SP 54® injection solution | - | - | - | - | [1] 19 19 |
319 | Pentosan polysulfate | [1] Pentosan polysulfate Pentosan polysulfate | [1] D05428
D05428
(Name: Pentosan polysulfate sodium) | - | - | [3] 19 19, 26, 226 |
320 | PENTOSAN POLYSULFATE SODIUM | [1] Pentosan polysulfate Pentosan polysulfate | [1] D05428
D05428
(Name: Pentosan polysulfate sodium) | - | - | [1] 19 19 |
321 | Pentosan polysulfate sodium 100 mg | [1] Pentosan polysulfate Pentosan polysulfate | [1] D05428
D05428
(Name: Pentosan polysulfate sodium) | - | - | [1] 226 226 |
322 | Pentosan Polysulphate SP54 | - | - | - | - | [1] 19 19 |
323 | Pentosan Polysulphate SP54® | - | - | - | - | [1] 19 19 |
324 | Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie | [1] Tazobactam Tazobactam (Synonym: Piperacillin / Tazobactam Powder for Injection) | [1] D00660
D00660
| - | - | [1] 299 299 |
325 | Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie | [1] Tazobactam Tazobactam (Synonym: Piperacillin / Tazobactam Powder for Injection) | [1] D00660
D00660
| - | - | [1] 299 299 |
326 | PLACENTEX ® Polydeoxyribonucleotide | - | - | - | - | [1] 51 51 |
327 | PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml | - | - | - | - | [1] 51 51 |
328 | Plaquenil - Hydroxychloroquine 200mg Film coated tablets (Synonym: Polirreumin (TN)) | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [3] 43 43, 44, 45 |
329 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) | - | - | - | - | [2] 13 13, 14 |
330 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE | [4] Aluminium Aluminium (Synonym: Aluminum powder), Aluminium phosphate, Corynebacterium diphtheriae CRM197 protein, Phosphate ion | - | - | - | [1] 46 46 |
331 | Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F | - | - | - | - | [1] 46 46 |
332 | Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F | - | - | - | - | [1] 46 46 |
333 | Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F | - | - | - | - | [1] 222 222 |
334 | Pneumococcal polysaccharide serotype 11 2.2 µg | - | - | - | - | [1] 222 222 |
335 | Pneumococcal polysaccharide vaccine | - | - | - | - | [3] 13 13, 46, 222 |
336 | PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT) | - | - | - | - | [1] 46 46 |
337 | Pneumococcal polysaccharide vaccine 23 valent | - | - | - | - | [1] 265 265 |
338 | Pneumococcal polysaccharide vaccine solution for injection in a vial | - | - | - | - | [1] 222 222 |
339 | Pneumovax® (pneumococcal polysaccharide vaccine) | - | - | - | - | [1] 65 65 |
340 | PO | - | - | - | - | [1] 13 13 |
341 | PO azithromycin | [1] Azithromycin Azithromycin | [3] D02134
D02134
,
D06390
,
D07486
| - | - | [1] 299 299 |
342 | PO ciprofloxacin | [1] Ciprofloxacin Ciprofloxacin | [2] D00186
D00186
,
D02216
| - | - | [1] 299 299 |
343 | POL6014 | - | - | - | - | [1] 299 299 |
344 | POL7080 | - | - | - | - | [1] 299 299 |
345 | Polaprezinc | [1] Polaprezinc Polaprezinc | [1] D01611
D01611
(Name: Polaprezinc) | - | - | [2] 96 96, 97 |
346 | Polidocanol | [1] Polidocanol Polidocanol | [1] D01993
D01993
(Name: Polidocanol) | - | - | [1] 279 279 |
347 | Poly ICLC | - | - | - | - | [1] 34 34 |
348 | POLY(OXY-1,2-ETHANEDIYL), A | - | - | - | - | [1] 235 235 |
349 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2- | [1] Diethyl ether Diethyl ether | [1] D01772
D01772
| - | - | [1] 235 235 |
350 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DI | [1] Diethyl ether Diethyl ether | [1] D01772
D01772
| - | - | [1] 235 235 |
351 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL]-2-METHYLALANYL-TERIPARATIDE (2:1) | [2] Diethyl ether Diethyl ether, Teriparatide | [2] D01772
D01772
,
D06078
| [1] PTH1R PTH1R 💬 | [3] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 |
352 | POLY-L-LACTIC ACID | [3] L-Lactic acid L-Lactic acid, Lactic acid (Synonym: Potassium Chloride in Lactated Ringers and Dextrose), Poly(lactic acid) | [1] D00111
D00111
| - | - | [1] 265 265 |
353 | Polyclonal IgG | - | - | - | - | [1] 65 65 |
354 | POLYDEOXYRIBONUCLEOTIDES | - | - | - | - | [2] 51 51, 70 |
355 | Polyethylene glycol | [1] Polyethylene glycol Polyethylene glycol | [1] D03370
D03370
(Name: Polyethylene glycol 3350) | - | - | [7] 6 6, 78, 96, 97, 235, 276, 299 |
356 | Polyethylene Glycol 3350 | [1] Polyethylene glycol Polyethylene glycol | [1] D03370
D03370
(Name: Polyethylene glycol 3350) | - | - | [2] 96 96, 299 |
357 | PolyMVA | - | - | - | - | [1] 2 2 |
358 | Polyphenon E | - | - | - | - | [2] 13 13, 36 |
359 | Polyphenon E® | - | - | - | - | [1] 97 97 |
360 | Pomalidomida | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
(Name: Pomalidomide) | [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 |
361 | Pomalidomide | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
(Name: Pomalidomide) | [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [6] 28 28, 34, 51, 85, 227, 331 |
362 | Pomalidomide (CC-4047 | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
(Name: Pomalidomide) | [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 |
363 | Pomalidomide (CC-4047) | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
(Name: Pomalidomide) | [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 |
364 | Pomalidomide and Dexamethasone | [2] Dexamethasone Dexamethasone (Synonym: Neo-poly-dex), Pomalidomide | [10] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
,
D08976
(Name: Pomalidomide) | [3] IL6 IL6, NR3C1, TNF 💬 | [81] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 |
365 | Pomalidomide Oral Product | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
(Name: Pomalidomide) | [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 227 227 |
366 | Pomegranate | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 |
367 | PONESIMOD | [1] Ponesimod Ponesimod | [1] D11215
D11215
(Name: Ponesimod) | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
368 | Ponesimod 10 mg | [1] Ponesimod Ponesimod | [1] D11215
D11215
(Name: Ponesimod) | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
369 | Ponesimod 20 mg | [1] Ponesimod Ponesimod | [1] D11215
D11215
(Name: Ponesimod) | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
370 | Ponesimod 40 mg | [1] Ponesimod Ponesimod | [1] D11215
D11215
(Name: Ponesimod) | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
371 | Ponticelli Regimen | - | - | - | - | [1] 222 222 |
372 | Pooled mesenchymal stem cell | - | - | - | - | [1] 49 49 |
373 | Pooled Plasma (Human), Solvent/Detergent Treated | - | - | - | - | [1] 64 64 |
374 | Porcine (pig) PERT | - | - | - | - | [1] 299 299 |
375 | Porcine PERT | - | - | - | - | [1] 299 299 |
376 | Porphobilinogen | [1] Porphobilinogen Porphobilinogen | - | - | - | [1] 254 254 |
377 | Posaconazole | [1] Posaconazole Posaconazole | [1] D02555
D02555
(Name: Posaconazole) | - | - | [4] 60 60, 65, 96, 299 |
378 | Posaconazole (PSZ) | [1] Posaconazole Posaconazole | [1] D02555
D02555
(Name: Posaconazole) | - | - | [1] 65 65 |
379 | Posaconazole 100 MG [Noxafil] | [1] Posaconazole Posaconazole | [1] D02555
D02555
(Name: Posaconazole) | - | - | [1] 299 299 |
380 | Posaconazole 40 MG/ML | [1] Posaconazole Posaconazole | [1] D02555
D02555
(Name: Posaconazole) | - | - | [1] 299 299 |
381 | Posaconazole Delayed Release Oral Tablet | [1] Posaconazole Posaconazole | [1] D02555
D02555
(Name: Posaconazole) | - | - | [1] 96 96 |
382 | POSACONAZOLO | - | - | - | - | [1] 299 299 |
383 | Posiphen | [1] Posiphen Posiphen | - | - | - | [1] 6 6 |
384 | Positive expiratory pressure | - | - | - | - | [1] 299 299 |
385 | Positron Emission Tomography | - | - | - | - | [4] 40 40, 46, 49, 96 |
386 | Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin) | [1] Activated charcoal Activated charcoal (Synonym: Trousse Antipoison Pour Enfants Liq) | - | - | - | [1] 6 6 |
387 | Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin) | - | - | - | - | [1] 6 6 |
388 | Post-CPB Drug: Dobutamine Hydrochloride | [1] Dobutamine Dobutamine | [4] D00632
D00632
,
D03879
,
D03880
,
D03881
| [1] ADRB1 ADRB1 💬 | [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
389 | Posterior RA | - | - | - | - | [1] 75 75 |
390 | Posterolateral spinal fusion with instrumentation | [1] Iron polymaltose Iron polymaltose | - | - | - | [1] 70 70 |
391 | Postoperative 3-month exclusive enteral nutrition | - | - | - | - | [1] 96 96 |
392 | Potassium | [1] Potassium Potassium | [1] D08403
D08403
(Name: Potassium) | - | - | [12] 36 36, 46, 66, 67, 88, 94, 98, 115, 167, 179, 215, 235 |
393 | Potassium sparing diuretic | [1] Potassium Potassium | [1] D08403
D08403
(Name: Potassium) | - | - | [1] 235 235 |
394 | Potassium supplement | [1] Potassium Potassium | [1] D08403
D08403
(Name: Potassium) | - | - | [1] 46 46 |
395 | Potiga | [1] Ezogabine Ezogabine (Synonym: Potiga) | [1] D09569
D09569
(Name: Potiga (TN)) | [5] KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 | [6] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | [1] 144 144 |
396 | Powder for Oral Suspension) | - | - | - | - | [1] 113 113 |
397 | Power doppler ultrasonography | - | - | - | - | [1] 46 46 |
398 | PowerLung trainer | - | - | - | - | [1] 2 2 |
399 | Pozelimab | [1] Pozelimab Pozelimab | [1] D11477
D11477
(Name: Pozelimab) | [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2] 11 11, 62 |
400 | Pozelimab (REGN3918) + Cemdisiran | [2] Cemdisiran Cemdisiran, Pozelimab | [1] D11477
D11477
(Name: Pozelimab) | [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 |
401 | Pre and post-CPB Drug: Dobutamine Hydrochloride | [1] Dobutamine Dobutamine | [4] D00632
D00632
,
D03879
,
D03880
,
D03881
| [1] ADRB1 ADRB1 💬 | [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
402 | PREDNISON 5, 20 Léciva por. tablet nob | - | - | - | - | [1] 50 50 |
403 | Prednison 5, 20 Léciva por. tablet nob. | - | - | - | - | [1] 50 50 |
404 | Prednisone (and methylprednisolone) (Synonym: POINT OF CARE L2) | [2] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Prednisone | [7] D00407
D00407
,
D00473
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 |
405 | Prednisone, methylprednisolone,cyclophosphamides (Synonym: POINT OF CARE L2) | [2] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Prednisone | [7] D00407
D00407
,
D00473
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 |
406 | Privigen 100 mg/ml, solution pour perfusion | - | - | - | - | [1] 53 53 |
407 | Promixin 1 million International Units (IU) Powder for Nebuliser Solution | - | - | - | - | [1] 299 299 |
408 | Promixin, 1 million International Units (IU) Powder for Nebuliser Solution | - | - | - | - | [1] 299 299 |
409 | Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador | - | - | - | - | [1] 299 299 |
410 | Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal) | - | - | - | - | [1] 13 13 |
411 | Pseudoephedrine (Synonym: Pseudoephedrine polistirex) | [1] Pseudoephedrine Pseudoephedrine (Synonym: Poly-Vent DM) | [4] D00485
D00485
,
D05648
(Name: Pseudoephedrine polistirex),
D05649
,
D08449
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 |
412 | Pseudoephedrine + 480 ml water (Synonym: Pseudoephedrine polistirex) | [2] Pseudoephedrine Pseudoephedrine (Synonym: Poly-Vent DM), Water (Synonym: Ori-power) | [5] D00001
D00001
,
D00485
,
D05648
(Name: Pseudoephedrine polistirex),
D05649
,
D08449
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 |
413 | Pseudoephedrine + 50 ml water (Synonym: Pseudoephedrine polistirex) | [2] Pseudoephedrine Pseudoephedrine (Synonym: Poly-Vent DM), Water (Synonym: Ori-power) | [5] D00001
D00001
,
D00485
,
D05648
(Name: Pseudoephedrine polistirex),
D05649
,
D08449
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 |
414 | Psyllium Husk Powder | [1] Plantago seed Plantago seed (Synonym: Lidl Orange Smooth Fiber Powder Naturally and Artificially Flavored) | [1] D05525
D05525
| - | - | [1] 97 97 |
415 | Quinidine (Synonym: Quinidine polygalacturonate) | [1] Quinidine Quinidine | [4] D00642
D00642
,
D00643
(Name: Quinidine polygalacturonate),
D02272
,
D08458
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [3] 2 2, 8, 13 |
416 | Quinidine Sulfate (Synonym: Quinidine polygalacturonate) | [2] Quinidine Quinidine, Sulfate ion | [4] D00642
D00642
,
D00643
(Name: Quinidine polygalacturonate),
D02272
,
D08458
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 13 13 |
417 | Radiation: PET (Positron Emission Tomography) Study | - | - | - | - | [1] 17 17 |
418 | Radiolabelled OligoG CF-5/20 Dry Powder for Inhalation (DPI) | - | - | - | - | [1] 299 299 |
419 | Raptiva 100 mg/ml powder and solvent for solution for injection | [1] Efalizumab Efalizumab | [1] D03959
D03959
| [1] ITGAL ITGAL 💬 | [12] Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [7] 11 11, 13, 46, 53, 61, 95, 96 |
420 | Recombinant human porphobilinogen deaminase (Porphozym) | [1] Porphobilinogen Porphobilinogen | - | - | - | [1] 254 254 |
421 | Recombinant porcine coagulation factor VIII (B domain deleted) | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 |
422 | Recombinant porcine coagulation factor VIII (B-domain deleted) | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 |
423 | REMICADE - 100 MG POLVERE PER CONCENTRATO PER INFUSIONE ENDOVENOSA 1 FLACONE VETRO 20 ML USO EV | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
424 | REMICADE 100 mg polvo para concentrado para solución para perfusión | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 271 |
425 | Remicade 100 mg powder for concentrate for solution for infusion. | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
426 | REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
427 | RETIGABINE/EZOGABINE (Synonym: Potiga (TN)) | [1] Ezogabine Ezogabine (Synonym: Potiga) | [1] D09569
D09569
(Name: Potiga (TN)) | [5] KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 | [6] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | [1] 144 144 |
428 | Revatio 10 mg/ml powder for oral suspension | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
429 | Revatio POS | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
430 | RT234 - vardenafil inhalation powder | [1] Vardenafil Vardenafil | [3] D02731
D02731
,
D03260
,
D08668
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
431 | S-Warfarin (Synonym: Warfarin potassium) | [2] (S)-Warfarin (S)-Warfarin, Warfarin | [3] D00564
D00564
,
D01280
(Name: Warfarin potassium),
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 13 13 |
432 | Saizen 8mg click.easy powder for solution for injection | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
433 | Saizen 8mg click.easy power for solution for injection | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
434 | SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI | - | - | - | - | [1] 67 67 |
435 | Scorpio NRG posterior stabilized (PS) | - | - | - | - | [1] 46 46 |
436 | Serial night time position splint | - | - | - | - | [1] 51 51 |
437 | Sildenafil and Losartan (Synonym: Losartan potassium) | [2] Losartan Losartan (Synonym: Losartan Potassium and Hydrochlorothiazide), Sildenafil | [4] D00357
D00357
(Name: Losartan potassium),
D02229
,
D08146
,
D08514
| [2] AGTR1 AGTR1, PDE5A 💬 | [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
438 | Single-point cane (SPC) | - | - | - | - | [1] 13 13 |
439 | Sinvastatina Sandoz 40 mg comprimidos revestidos por película | - | - | - | - | [1] 13 13 |
440 | Sirolimus and Hydroxychloroquine 200 mg (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [2] D00753
D00753
,
D08050
(Name: Polirreumin (TN)) | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 |
441 | Sirolimus and Hydroxychloroquine 400 mg (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [2] D00753
D00753
,
D08050
(Name: Polirreumin (TN)) | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 |
442 | Sodium phosphate enema, oral rifaximin and polyethylene glycol | [3] Phosphate ion Phosphate ion, Polyethylene glycol, Rifaximin | [2] D02554
D02554
,
D03370
(Name: Polyethylene glycol 3350) | - | - | [1] 6 6 |
443 | SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML | - | - | - | - | [3] 13 13, 14, 53 |
444 | SOLU MEDROL - 40 MG/ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 40 MG/ML | - | - | - | - | [1] 56 56 |
445 | SOLU MEDROL - 500 MG/8 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 500 MG+ FIALA SOLVENTE DA 8 ML | - | - | - | - | [1] 56 56 |
446 | Solu-Cortef, powder for solution for injection, 100mg, and 'Act-O-Vial' | [2] Hydrocortisone Hydrocortisone (Synonym: Post Treatment Balm), Hydrocortisone succinate | [2] D00088
D00088
,
D01442
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 6 6 |
447 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
448 | SPECT Imaging (180 Minutes post-injection) | - | - | - | - | [1] 46 46 |
449 | SPECT Imaging (60 Minutes post-injection) | - | - | - | - | [1] 46 46 |
450 | Status Post Lung Transplant | - | - | - | - | [1] 228 228 |
451 | Sulfasalazine + Hydroxychloroquine (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Sulfasalazine | [2] D00448
D00448
,
D08050
(Name: Polirreumin (TN)) | - | - | [1] 46 46 |
452 | Sulfate d'hydroxychloroquine (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Sulfate ion | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [1] 53 53 |
453 | Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] D05962
D05962
| - | - | [1] 215 215 |
454 | Sulphasalazine + Hydroxychloroquine OR Prednisolone (Synonym: Polirreumin (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Prednisolone | [9] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D08050
(Name: Polirreumin (TN)) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
455 | Sweet polvilho | - | - | - | - | [1] 257 257 |
456 | Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker | - | - | - | - | [1] 62 62 |
457 | Tedizolid PO | [1] Tedizolid Tedizolid | [1] D09685
D09685
| - | - | [1] 299 299 |
458 | Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. | [1] Teicoplanin Teicoplanin | [1] D02142
D02142
| - | - | [1] 299 299 |
459 | Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleava | [2] Polyethylene glycol Polyethylene glycol, Teriparatide | [2] D03370
D03370
(Name: Polyethylene glycol 3350),
D06078
| [1] PTH1R PTH1R 💬 | [3] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 |
460 | Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker | [2] Polyethylene glycol Polyethylene glycol, Teriparatide | [2] D03370
D03370
(Name: Polyethylene glycol 3350),
D06078
| [1] PTH1R PTH1R 💬 | [3] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 |
461 | The 0.5 mL dose of vaccine contains 25 micrograms of each of the following 23 pneumococcal polysaccharide | - | - | - | - | [1] 222 222 |
462 | The generic name is warfarin and many producers will be involved (Synonym: Warfarin potassium) | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
(Name: Warfarin potassium),
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 49 49 |
463 | The investigational medicinal product (IMP) may be labelled as either PF-04236921 106 mg/vial, Clonal SC lyophilized form” or PF-04236921 Powder for Injection, 106 mg/vial”. Supplies labelled with either nomenclature are equivalent. | - | - | - | - | [1] 96 96 |
464 | The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA | - | - | - | - | [1] 96 96 |
465 | The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA. | - | - | - | - | [1] 96 96 |
466 | The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: | - | - | - | - | [1] 86 86 |
467 | The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: | - | - | - | - | [1] 86 86 |
468 | TIP (Tobramycin inhalation powder) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
469 | TIS (Tobramycin Inhalation Solution) (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
470 | TOBI (tobramycin) (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
471 | TOBI 300 mg/5 ml solución para inhalación por nebulizador | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
472 | TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
473 | Tobi 300mg/5ml Solución para inhalación por nebulizador. | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
474 | TOBI PODHALER | - | - | - | - | [1] 299 299 |
475 | TOBI PODHALER - 28 MG POLVERE PER INALAZIONE CAPSULA RIGIDA USO INALATORIO BLISTER(ALU/ALU) 56 CAPSULE + 1 INALATORE | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
476 | TOBI Podhaler 28 mg Hartkapseln mit Pulver zur Inhalation | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
477 | TOBI Podhaler 28 mg inhalációs por, kemény kapszula | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
478 | TOBI PODHALER*448CPS 28MG+10IN | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
479 | TOBI™ Podhaler™ 112 mg inhaled twice daily | - | - | - | - | [1] 299 299 |
480 | Tobramicina polvere inalatoria | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
481 | TOBRAMYCIN (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
482 | Tobramycin (Gernebcin®) (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
483 | Tobramycin / Bramitob (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
484 | Tobramycin / TOBI (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
485 | Tobramycin 100 PARI (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
486 | Tobramycin dry powder | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
487 | Tobramycin for Inhalation (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
488 | Tobramycin Inhalation Powder | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
489 | Tobramycin Inhalation Powder (TIP) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
490 | Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
491 | Tobramycin inhalation solution (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
492 | Tobramycin Inhalation Solution (TIS) (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
493 | Tobramycin inhalation solution using a PARI LC® Plus nebulizer. (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
494 | Tobramycin injection 40mg/1ml (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
495 | Tobramycin nebulized nasally (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
496 | Tobramycin Powder | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
497 | Tobramycin Solution for Inhalation (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
498 | Tobramycin solution for inhalation (TOBI) (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
499 | Tobramycin solution for inhalation 300 mg (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
500 | Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
501 | TOBRAMYCIN SULFATE (Synonym: TOBI PODHALER) | [2] Sulfate ion Sulfate ion, Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
502 | Tofacitinib 5mg po bid | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
503 | Topotecan (Synonym: Potactasol (TN)) | [1] Topotecan Topotecan (Synonym: Potactasol) | [2] D02168
D02168
(Name: Potactasol (TN)),
D08618
| [1] TOP1 TOP1 💬 | - | [1] 25 25 |
504 | TOTTIZIM - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 10 ML | - | - | - | - | [1] 299 299 |
505 | Transdermal nicotine (Synonym: Nicotine polacrilex) | [1] Nicotine Nicotine (Synonym: Nicotac Nicotine Polacrilex Coated Cinnamon) | [3] D03365
D03365
,
D05156
,
D05157
(Name: Nicotine polacrilex) | [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [7] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | [1] 6 6 |
506 | Treatment with polyethylene glycol (Macrogol 4000) | [1] Polyethylene glycol Polyethylene glycol | [1] D03370
D03370
(Name: Polyethylene glycol 3350) | - | - | [1] 299 299 |
507 | Trekking pole (TP). | - | - | - | - | [1] 13 13 |
508 | Treprostinil Inhalation Powder | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
509 | Tripterygium wilfordii polyglycosidium | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [1] 224 224 |
510 | TYSABRI 300 mg solution à diluer pour perfusion | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
511 | Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) (Synonym: POINT OF CARE L2) | [2] Methylprednisolone Methylprednisolone (Synonym: Point Of Care LM DEP 2), Ursodeoxycholic acid | [7] D00407
D00407
,
D00734
,
D00751
,
D00979
(Name: POINT OF CARE L2),
D05000
,
D05001
,
D05002
| [2] NR1H4 NR1H4, NR3C1 💬 | [2] Bile secretion Bile secretion, Neuroactive ligand-receptor interaction 💬 | [1] 93 93 |
512 | US TAP Bupivacaine/Epinephrine (Synonym: POINT OF CARE KIT KM) | [2] Bupivacaine Bupivacaine, Epinephrine (Synonym: Posicaine N) | [5] D00095
D00095
,
D00996
,
D01450
(Name: POINT OF CARE KIT KM),
D02149
,
D07552
| [14] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 |
513 | VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135) | - | - | - | - | [3] 61 61, 62, 66 |
514 | Vancomycin hydrochloride inhalation powder | [1] Vancomycin Vancomycin | [2] D00212
D00212
,
D00926
| - | - | [1] 299 299 |
515 | Vancomycin inhalation powder | [1] Vancomycin Vancomycin | [2] D00212
D00212
,
D00926
| - | - | [1] 299 299 |
516 | Vantobra (tobramycin) (Synonym: TOBI PODHALER) | [1] Tobramycin Tobramycin (Synonym: Tobi Podhaler) | [2] D00063
D00063
(Name: TOBI PODHALER),
D02542
| - | - | [1] 299 299 |
517 | Versus hydroxychloroquine (Synonym: Polirreumin (TN)) | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
(Name: Polirreumin (TN)) | - | - | [1] 49 49 |
518 | VEYONDI 650IU powder and solvent for solution for injection | - | - | - | - | [1] 288 288 |
519 | VEYVONDI 1300I IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] D08681
D08681
| - | - | [1] 288 288 |
520 | VEYVONDI 1300IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] D08681
D08681
| - | - | [1] 288 288 |
521 | VEYVONDI 650IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] D08681
D08681
| - | - | [1] 288 288 |
522 | VFEND 40 mg/ml powder for oral suspension | [1] Voriconazole Voriconazole | [1] D00578
D00578
| - | - | [1] 299 299 |
523 | Vitamin D Powder | [1] Vitamin D Vitamin D (Synonym: Supravite Pour Enfants) | - | - | - | [1] 299 299 |
524 | Volixibat potassium | [2] Potassium Potassium, Volixibat | [2] D08403
D08403
(Name: Potassium),
D11007
| - | - | [1] 94 94 |
525 | VPRIV - 400 U - POLVERE PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO | [1] Velaglucerase alfa Velaglucerase alfa | [1] D09029
D09029
| [1] GBA GBA 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 |
526 | VPRIV 400 Units powder for solution of infusion | [1] Velaglucerase alfa Velaglucerase alfa | [1] D09029
D09029
| [1] GBA GBA 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 |
527 | Warfarin (Synonym: Warfarin potassium) | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
(Name: Warfarin potassium),
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [13] 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
528 | Warfarin 10 mg (Synonym: Warfarin potassium) | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
(Name: Warfarin potassium),
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [2] 96 96, 97 |
529 | Warfarin Potassium | [2] Potassium Potassium, Warfarin | [4] D00564
D00564
,
D01280
(Name: Warfarin potassium),
D08403
(Name: Potassium),
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 88 88 |
530 | Warfarin Sodium (Synonym: Warfarin potassium) | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
(Name: Warfarin potassium),
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 49 49 |
531 | Warfarin+ Vitamin K (Synonym: Warfarin potassium) | [2] Phylloquinone Phylloquinone, Warfarin | [4] D00148
D00148
,
D00564
,
D01280
(Name: Warfarin potassium),
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 46 46 |
532 | Whole body planar SPECT imaging (15 Minutes post-injection) | - | - | - | - | [1] 46 46 |
533 | Whole body planar SPECT imaging (18-20 Hours post-injection) | - | - | - | - | [1] 46 46 |
534 | Whole body planar SPECT imaging (180 Minutes post-injection) | - | - | - | - | [1] 46 46 |
535 | Whole body planar SPECT imaging (60 Minutes post-injection) | - | - | - | - | [1] 46 46 |
536 | Wuling Powder | - | - | - | - | [1] 6 6 |
537 | YONDELIS 0,25 mg polvo para concentrado para solución para perfusión | [1] Trabectedin Trabectedin | [1] D06199
D06199
| - | - | [1] 159 159 |
538 | Yondelis 0.25 mg powder for concentrate for solution for infusion. | [1] Trabectedin Trabectedin | [1] D06199
D06199
| - | - | [1] 159 159 |
539 | YONDELIS 1 mg polvo para concentrado para solución para perfusión | [1] Trabectedin Trabectedin | [1] D06199
D06199
| - | - | [1] 159 159 |
540 | Yondelis 1 mg powder for concentrate for solution for infusion. | [1] Trabectedin Trabectedin | [1] D06199
D06199
| - | - | [1] 159 159 |
541 | ZX008 (Fenfluramine Hydrochloride) (Synonym: Ponderax (TN)) | [1] Fenfluramine Fenfluramine (Synonym: Pondimin Tab 20mg) | [1] D07945
D07945
(Name: Ponderax (TN)) | [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 140 140, 144 |